Zygomaticomaxillary Osteomyelitis due to COVID-19 Associated Mucormycosis (CAM): A Case Series of 10 Patients

AIM: To highlight the incidence of osteomyelitis due to CAM and to elucidate the mode of spread of infection from maxilla to zygomatic bone, to highlight how that is distinct from other cases of zygomatic osteomyelitis due to other etiologies. METHODS: A standard protocol of treatment of the cases o...

Descripción completa

Detalles Bibliográficos
Autores principales: Datarkar, Abhay N., Daware, Surendra, Gadve, Vandana, Pardiwala, Arwa F., Pund, Mahesh, Bhawalkar, Amit, Purohit, Subodh, Relan, Priyanka, Ghormade, Ashlesha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer India 2022
Materias:
Clinical Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9568929/
https://www.ncbi.nlm.nih.gov/pubmed/36267537
http://dx.doi.org/10.1007/s12663-022-01809-z
Descripción
Sumario:AIM: To highlight the incidence of osteomyelitis due to CAM and to elucidate the mode of spread of infection from maxilla to zygomatic bone, to highlight how that is distinct from other cases of zygomatic osteomyelitis due to other etiologies. METHODS: A standard protocol of treatment of the cases of CAM with zygomatic involvement based on our own outcomes was furnished. All 10 patients were treated with dual antifungal therapy and aggressive surgical resection via extraoral approach, in conjunction with functional endoscopic sinus surgery (FESS). RESULTS: Ten out of 116 patients of CAM reporting to our institute presented with zygomatic bone involvement with an incidence rate averaging at 8.6%, whereas in previous literature osteomyelitis of zygomatic bone was extremely rare with an incidence pattern of just 1.42%. CONCLUSIONS: The treatment protocol followed by the authors gave good outcomes to all patients treated, with no mortalities.

Ejemplares similares